News Ticker

[ November 30, 2023 ] Cell Culture Manufacturing Specialist – TekwissenGroup – Berkeley, CA San Francisco Biotech Jobs
[ November 30, 2023 ] By the Bay Health, Mission Hospice & Home Care, and Hope Hospice Merge to Become the Largest Independent Not-for-Profit Hospice Network in Northern California News
[ November 30, 2023 ] Plant-based menstrual pads could help alleviate period poverty News
[ November 30, 2023 ] Atropos Health Forms Life Science Advisory Board, Increasing Commitment to Accelerated Drug Development and Clinical Trial Diversity and Inclusion News
[ November 30, 2023 ] PsiQuantum Announces New Government Advisory Board with Decades of Combined Public Service Across the White House, Departments of Defense and Commerce, Intelligence Community, and the U.S. Congress News

Gilead hands Arcellx $285M to expand BCMA cell therapy deal, sparking fresh push for congested market

November 15, 2023 San Francisco Biotechnology Network News News, Syndication Comments Off

Gilead hands Arcellx $285M to expand BCMA cell therapy deal, sparking fresh push for congested market
ntaylor
Wed, 11/15/2023 – 09:22
Click here to view original post

Copyright © 2023 Biotech Networks, LLC